Conclusion: The results of this systematic review and meta-analysis suggest that PEA is an effective and well-tolerated treatment for chronic pain. Further study is warranted to determine the optimal dosing and administration parameters of PEA for analgesic effects in the context of chronic pain.
PubMed 36986081 ↗Palmitoylethanolamide
The short answer. There isn't much data on Palmitoylethanolamide yet — 46 mentions, 10 with a clear outcome — so treat these numbers as anecdotal. It is most often used for pain & inflammation: 91% of 11 reports say that improved. It is well studied — 28 meta-analyses on PubMed.
From 46 mentions in total — the rest didn't say how it went and aren't counted.
What Palmitoylethanolamide does, according to users
Of the people who reported each effect, the share who said it got better.
3 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 28 meta-analyses on PubMed ↗ · 69 randomized trials ↗
Conclusion: Furthermore, both rehabilitation strategies and PEA-LUT administration have been associated with improvements in symptoms of brain fog. Future studies should explore combinations of interventions and include longer follow-up periods to assess the long-term effects of these treatments.
PubMed 38695969 ↗Conclusion: This study underscores the efficacy and tolerability of several pharmacotherapies in managing agitation among children and adults with ASD or ID. Our findings provide robust evidence that specific treatments, such as arbaclofen, risperidone plus buspirone and omega-3 fatty acids, are both effective and well-tolerated, offering valuable therapeutic options for clinicians. The study emphasizes the need for ongoing research to ensure that treatment strategies remain aligned with the evolving clinical landscape, ultimately improving patient outcomes in this challenging population.
PubMed 39690490 ↗Conclusion: Six of these studies (199 patients) were included in the systematic review after the study selection process, and three studies for meta-analysia. Overall, PEA showed significant efficacy in reducing IOP in patients, this encourages its clinical use in glaucoma as well as across different forms of eye disorders.
PubMed 38269580 ↗69 human trials on ClinicalTrials.gov test Palmitoylethanolamide — 33 completed, 12 recruiting now. See all on ClinicalTrials.gov ↗
- Ultra-Micronized vs Liposomal PEA 600 mg: A Crossover PK Study in Healthy Subjects · PK in Healthy Volunteers, Liposomal Encapsulation · 2026
- A Trial of the Fatty Acid Amide Hydrolase Inhibitor Palmitoylethanolamide in Bipolar Depression · Bipolar Depression · 2025
- Ultramicronized Palmitoylethanolamide for Smell, Taste in Children With Autism Spectrum Disorder. · Autism, Smell Dysfunction · 2025
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
NIH has funded 1 research project with Palmitoylethanolamide in the title, $2,051,325 in total (2023–2024). NIH RePORTER ↗
Dosage people report
As stated by users — not a recommendation. Follow the label or your doctor.
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“Just started taking Palmitoylethanolamide and have had some wonderful effects. Sleeping is easier and i feel more comfortable trying to fall asleep.”
“For the past few months she has been on PEA, 600mg b.i.d. ... Not only has her energy, pain, and skin improved dramatically”
“this stuff works so well. It treats inflammation and several types of hard to treat nerve pain such as fibromyalgia, and shingles. I use it for rosacea.”
“I already take PEA (palmitoylethanolamide) daily and that helps me keep my general sleep schedule and overall sleep health”
Top discussions (5)
- Things that upregulate 5 alpha reductase type 1, 3 alpha HSD type 1, and/or Allopregnanolone? ↗
- Ibuprofen alone increased the relative number of dopaminergic neurons by 47% (+ More For Those Quitting Amphetamine) ↗
- Anything new? ↗
- Nootropics that go Alongside Marijuana ↗
- 🔬 Curowhite and the Color of Curcumin 🔬 ↗
Other options for pain & inflammation
Sources
- User reports: 46 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- NIH RePORTER ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate